ReviewPharmaceutics2023

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease.

Alankrita Rani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.